Concepedia

Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience

Naoko Ishida, Kazuhiro Araki, Takehiko Sakai, Kokoro Kobayashi, Takayuki Kobayashi, Ippei Fukada, Mitsuchika Hosoda, Mitsugu Yamamoto, Kazuomi Ichinokawa, Shunji Takahashi,

Breast Cancer · 2015 · 11 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +9

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

Weiyi Toy, Yang Shen, Helen Won et al. · Nature Genetics · 2013 · 1.3K citations · Full text

, , +9

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

Dan R. Robinson, Yi-Mi Wu, Pankaj Vats et al. · Nature Genetics · 2013 · 1.2K citations · Full text

, , +14

A potent specific pure antiestrogen with clinical potential.

A. E. Wakeling, Michael Dukes, Jean Bowler · PubMed · 1991 · 1.1K citations

, , +8

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, C. Bourgier, Claire Cropet et al. · Journal of Clinical Oncology · 2012 · 709 citations · Full text

, , +17